Fractyl Health Investor Relations Material
Latest events
Q4 2024
Fractyl Health
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Fractyl Health Inc
Access all reports
Fractyl Health Inc. is a healthcare biotechnology company dedicated to the development of innovative therapies for metabolic diseases, particularly type 2 diabetes (T2D) and obesity. The company's main therapeutic platforms include Revita DMR and Rejuva. Revita DMR is an outpatient procedural therapy aimed at modifying duodenal dysfunction—a condition influenced by a high-fat and high-sugar diet which can lead to T2D and obesity. Rejuva represents a novel gene therapy platform, delivered via adeno-associated virus, designed to achieve long-term remission of T2D and obesity by altering metabolic hormone function in pancreatic islet cells. The company is headquartered in Burlington, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
GUTS
Country
🇺🇸 United States